Dr. Carnevale is an Assistant Professor at UCSF in the UCSF-Gladstone Institute of Genomic Immunology. Dr. Carnevale obtained her MD at Harvard Medical School, completed her internal medicine residency and hematology/oncology fellowship training at UCSF, and sub-specialized in GI Oncology. Dr. Carnevale completed her postdoctoral training at UCSF where she was co-mentored by Dr. Alan Ashworth and Dr. Alex Marson. Dr. Carnevale has focused her early work on developing technologies to enable genome-wide CRISPR screening in primary human T cells (Shifrut and Carnevale et al., Cell, 2018) and harnessing these technologies to discover new ways to enhance immune cell therapies for cancer treatment (Carnevale and Shifrut et al., Nature, 2022). The Carnevale lab focuses on developing new ways to model intra-tumoral conditions to discover genetic engineering strategies to rewire immune cells for cancer treatment. Dr. Carnevale is also involved in clinical trials to test immunotherapies, including cell therapies, in solid tumors and refractory hematological cancers.